|
[1]
|
Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Disease. The Lancet, 397, 2212-2224. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zhou, F., Zhou, J., Wang, W., Zhang, X., Ji, Y., Zhang, P., et al. (2019) Unexpected Rapid Increase in the Burden of NAFLD in China from 2008 to 2018: A Systematic Review and Meta‐Analysis. Hepatology, 70, 1119-1133. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Munjas, J., Vladimirov, S., Ratkovic, T., Comi, L., Giglione, C., Tanaskovic, I., et al. (2025) Toward Precision Medicine in Atherosclerotic Cardiovascular Disease: Insights from Omics Data into Sex Differences. Current Atherosclerosis Reports, 28, Article No. 5. [Google Scholar] [CrossRef]
|
|
[4]
|
Choe, H.J., Almas, T., Neeland, I.J., Lim, S. and Després, J. (2025) Obesity Phenotypes and Atherogenic Dyslipidemias. European Journal of Clinical Investigation, 56, e70151. [Google Scholar] [CrossRef]
|
|
[5]
|
Wang, J., Xu, C., Xun, Y., Lu, Z., Shi, J., Yu, C., et al. (2015) ZJU Index: A Novel Model for Predicting Nonalcoholic Fatty Liver Disease in a Chinese Population. Scientific Reports, 5, Article No. 16494. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Xu, Y., Zhao, J. and Yang, L. (2024) Epidemic Status and Risk Factors of Non-Alcoholic Fatty Liver Disease. Chinese General Practice, 27, 3825-3834.
|
|
[7]
|
Husaema, M., Saleh, L.M., Naiem, M.F., Wahyu, A. and D, D. (2025) Occupational and Lifestyle Risk Factors Associated with Metabolic Fatty Liver Disease among University Staff in Indonesia. Frontiers in Public Health, 13, Article ID: 1739931. [Google Scholar] [CrossRef]
|
|
[8]
|
Morawska, A., Frankowski, R., Grabarczyk, M., Kosmalski, M. and Różycka-Kosmalska, M. (2025) Crosstalk between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life, 15, Article 1713. [Google Scholar] [CrossRef]
|
|
[9]
|
Grander, C., Grabherr, F. and Tilg, H. (2023) Non-Alcoholic Fatty Liver Disease: Pathophysiological Concepts and Treatment Options. Cardiovascular Research, 119, 1787-1798. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zheng, K., Yin, Y., Guo, H., Ma, L., Liu, R., Zhao, T., et al. (2024) Association between the ZJU Index and Risk of New-Onset Non-Alcoholic Fatty Liver Disease in Non-Obese Participants: A Chinese Longitudinal Prospective Cohort Study. Frontiers in Endocrinology, 15, Article ID: 1340644. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Shi, M., Liu, P., Li, J., Su, Y., Zhou, X., Wu, C., et al. (2021) The Performance of Noninvasive Indexes of Adults in Identification of Nonalcoholic Fatty Liver Disease in Children. Journal of Diabetes, 13, 744-753. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zhang, M., Yu, M., Shen, X. and Kang, G. (2025) Zhejiang University Index Predicts Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients. World Journal of Diabetes, 16, Article 114565. [Google Scholar] [CrossRef]
|
|
[13]
|
Tao, X., Pan, T., Zhong, X. and Pan, X. (2025) Association between Zhejiang University Index and Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus. World Journal of Diabetes, 16, Article 110406. [Google Scholar] [CrossRef]
|
|
[14]
|
Gouda, M.M. (2025) From Fatty Liver Indices to the Zhejiang University Index: Re-Shaping Risk Stratification of Metabolic Liver Disease in Diabetes. World Journal of Diabetes, 16, Article 115435. [Google Scholar] [CrossRef]
|
|
[15]
|
Mo, Z., Chen, B. and Wu, M. (2025) Associations of the Zhejiang University (ZJU) Index with Cardiovascular Diseases and Mortality among US Adults: A National Cohort Study. Lipids in Health and Disease, 24, Article No. 374. [Google Scholar] [CrossRef]
|
|
[16]
|
Zhang, H., Li, X., Lian, X., Sun, J., Wang, X., Zhang, M., et al. (2025) The ZJU Index as a Predictor of All-Cause Mortality in Metabolic Syndrome Patients: A Prospective Cohort Study from NHANES 2005-2018. Medicine, 104, e44203. [Google Scholar] [CrossRef]
|
|
[17]
|
Mustafa, A., Kite, C., Lagojda, L., Dallaway, A., Chatha, K.K., Than, N.N., et al. (2025) Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review. International Journal of Molecular Sciences, 26, 11275. [Google Scholar] [CrossRef]
|
|
[18]
|
Rinella, M.E., Neuschwander-Tetri, B.A., Siddiqui, M.S., Abdelmalek, M.F., Caldwell, S., Barb, D., et al. (2023) AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease. Hepatology, 77, 1797-1835. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Virani, S.S., Newby, L.K., Arnold, S.V., et al. (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 148, e9-e119.
|
|
[20]
|
Masarone, M., Rosato, V., Dallio, M., Gravina, A.G., Aglitti, A., Loguercio, C., et al. (2018) Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 9547613. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta‐Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., et al. (2019) Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology, 69, 2672-2682. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Rinella, M.E., Lazarus, J.V., Ratziu, V., Francque, S.M., Sanyal, A.J., Kanwal, F., et al. (2023) A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature. Journal of Hepatology, 79, 1542-1556. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Younossi, Z.M., Paik, J.M., Stepanova, M., Ong, J., Alqahtani, S. and Henry, L. (2024) Clinical Profiles and Mortality Rates Are Similar for Metabolic Dysfunction-Associated Steatotic Liver Disease and Non-Alcoholic Fatty Liver Disease. Journal of Hepatology, 80, 694-701. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kim, K., Hong, S., Han, K. and Park, C. (2024) Association of Non-Alcoholic Fatty Liver Disease with Cardiovascular Disease and All Cause Death in Patients with Type 2 Diabetes Mellitus: Nationwide Population Based Study. BMJ, 384, e076388. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Byrne, C.D. and Targher, G. (2022) Non-Alcoholic Fatty Liver Disease Is a Risk Factor for Cardiovascular and Cardiac Diseases: Further Evidence That a Holistic Approach to Treatment Is Needed. Gut, 71, 1695-1696. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Brunner, K.T., Pedley, A., Massaro, J.M., Hoffmann, U., Benjamin, E.J. and Long, M.T. (2020) Increasing Liver Fat Is Associated with Incident Cardiovascular Risk Factors. Clinical Gastroenterology and Hepatology, 18, 1884-1886. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Di Bonito, P., Valerio, G., Licenziati, M.R., Di Sessa, A., Miraglia del Giudice, E., Morandi, A., et al. (2022) Uric Acid versus Metabolic Syndrome as Markers of Fatty Liver Disease in Young People with Overweight/Obesity. Diabetes/Metabolism Research and Reviews, 38, e3559. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Feng, R., Du, S., Wang, C., Li, Y., Liu, L., Guo, F., et al. (2014) Lean-Non-Alcoholic Fatty Liver Disease Increases Risk for Metabolic Disorders in a Normal Weight Chinese Population. World Journal of Gastroenterology, 20, 17932-17940. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Fracanzani, A.L., Petta, S., Lombardi, R., Pisano, G., Russello, M., Consonni, D., et al. (2017) Liver and Cardiovascular Damage in Patients with Lean Nonalcoholic Fatty Liver Disease, and Association with Visceral Obesity. Clinical Gastroenterology and Hepatology, 15, 1604-1611.e1. [Google Scholar] [CrossRef] [PubMed]
|